ANAGENESIS
ANAGENESIS
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Illkirch-graffenstaden, Alsace, France
Country:
France
Website Url:
http://www.anagenesis-biotech.com
Total Employee:
1+
Status:
Active
Contact:
617 583 1350
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Typekit Squarespace GlobalSign Domain Verification Squarespace Add To Cart
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.anagenesis-biotech.com Semrush global rank: 5.75 M Semrush visits lastest month: 1.45 K
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Anagenesis"
Anagenesis - Crunchbase Company Profile & Funding
Anagenesis is a preclinical‐stage stem cell-based company. Search Crunchbase. Start Free Trial . ... Contact Email [email protected]; Phone Number 617 583 1350; Lists Featuring This Company. ... 1,308 Number of …See details»
Anagenesis Biotechnologies - Crunchbase Company Profile
9,701 Number of Organizations • $6.3B Total Funding Amount • 5,603 Number of Investors Track Europe, Middle East, and Africa (EMEA) Biotechnology Companies (Top 10K)See details»
Anagenesis - VentureRadar
Anagenesis Biotechnologies is a private company developing new treatments against muscle diseases (genetic such as DMD and chronic such as sarcopenia and cachexia). The company …See details»
Anagenesis Biotechnologies - PitchBook
Anagenesis Biotechnologies General Information Description. Developer of novel treatments designed for genetic and age-related muscle degenerative diseases. The company owns a …See details»
Anagenesis Biotechnologies - Products, Competitors, Financials ...
Nov 24, 2018 Anagenesis Biotechnologies Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24092018 Prices from USD $250. Nov 24, 2018. 03:43 EST 24 Nov …See details»
Anagenesis Biotechnologies Information - RocketReach
Anagenesis has exclusive rights to two key patents from the French national biomedical research agency INSERM. Two main activities will generate revenues: a) Cell therapy for genetic …See details»
ANAGENESIS BIOTECHNOLOGIES - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ANAGENESIS BIOTECHNOLOGIES of ILLKIRCH GRAFFENSTADEN, GRAND EST. Get the latest business …See details»
Anagenesis Biotechnologies - Drug pipelines, Patents, Clinical trials ...
Jun 16, 2024 Explore Anagenesis Biotechnologies with its drug pipeline, therapeutic area, technology platform, .See details»
Anagenesis Biotechnologies - Overview, News & Similar
Anagenesis Biotechnologies is backed by a solid, experienced team led by its President & CEO, Dr. Jean-Yves Bonnefoy, coming from the Pharma & Biotech industry. Anagenesis …See details»
Anagenesis Biotechnologies Company Profile - Craft
Anagenesis Biotechnologies has 5 employees at their 1 location. See insights on Anagenesis Biotechnologies including office locations, competitors, revenue, financials, executives, …See details»
Anagenesis Biotechnologies | Strasbourg, Alsace, France Startup
ANAGENESIS created a unique technology platform for the development of new therapeutic strategies for muscle, skeleton and skin disorders. Find investment information and connect …See details»
Jean-Yves Bonnefoy - Co-Founder, President and CEO
Primary Organization . Anagenesis . Location Illkirch ... Jean-Yves Bonnefoy is the Co-Founder, CEO and President of Anagenesis. He previously worked at ALMS THERAPEUTICS as a …See details»
Anagenesis Biotechnologies - Company Profile - Tracxn
Aug 17, 2021 Anagenesis Biotechnologies - Developer of small molecules and cell therapy to treat genetic diseases. This company is not active anymore. Raised a total funding of $3.4M …See details»
CRISPR Therapeutics and Anagenesis… | CRISPR Therapeutics
Jun 8, 2016 Anagenesis Biotechnologies in Illkirch, France, is now focusing on HTS and HCS screens, while its newly formed US-subsidiary in Boston, MA, Anagenesis Biotherapies Inc., is …See details»
Dr Jean-Yves BONNEFOY - MATWIN
Jean-Yves Bonnefoy is CEO of Anagenesis Biotechnologies since January 2014. He is also President of the Life Sciences Competitiveness Cluster, Alsace BioValley, Board member of …See details»
Anagenesis - Contacts, Employees, Board Members, Advisors
Anagenesis has 1 current employee profile, Co-Founder, President and CEO Jean-Yves Bonnefoy. Anagenesis has 1 board member or advisor, Jean-Francois Rax . ContactsSee details»
Anagenesis Biotechnologies
Anagenesis BiotechnologiesSee details»
Anagenesis Biotechnologies lance sa filiale américaine
Apr 19, 2016 Anagenesis Biotechnologies, entreprise développant des traitements dérivés de cellules souches pour les maladies musculaires, a annoncé aujourd'hui la création de sa filiale …See details»
CRISPR And Anagenesis Biotechnologies Announce Strategic In
Jun 8, 2016 Anagenesis Biotechnologies is backed by a solid, experienced team led by its President & CEO, Dr. Jean-Yves Bonnefoy, coming from the Pharma & Biotech industry. …See details»